Tackling tumor immunosuppression by reprograming eicosanoid metabolism and signaling in the tumor microenvironment KU Leuven
Despite numerous advances achieved in cancer treatment, the prognosis for patients with liver malignancies still remains poor. Indeed, one of the three most common causes of cancer-related death is represented by liver cancer, accounting for around 1 million deaths per year, to which one has to add all the deaths due to metastasis in the liver – the preferred niche of many tumor types, including melanoma. The liver is a complex organ that ...